AstraZeneca PLC (AZN)
Total Valuation
AstraZeneca has a market cap or net worth of $224.79 billion. The enterprise value is $249.83 billion.
| Market Cap | 224.79B |
| Enterprise Value | 249.83B |
Important Dates
The last earnings date was Thursday, April 27, 2023, before market open.
| Earnings Date | Apr 27, 2023 |
| Ex-Dividend Date | Feb 23, 2023 |
Share Statistics
AstraZeneca has 3.10 billion shares outstanding.
| Shares Outstanding | 3.10B |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 18.10% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 48.03 and the forward PE ratio is 18.42. AstraZeneca's PEG ratio is 1.38.
| PE Ratio | 48.03 |
| Forward PE | 18.42 |
| PS Ratio | 5.13 |
| Forward PS | 4.35 |
| PB Ratio | 6.28 |
| P/FCF Ratio | 24.81 |
| PEG Ratio | 1.38 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.20, with an EV/FCF ratio of 27.58.
| EV / Earnings | 53.10 |
| EV / Sales | 5.70 |
| EV / EBITDA | 22.20 |
| EV / EBIT | 44.76 |
| EV / FCF | 27.58 |
Financial Position
The company has a current ratio of 0.90, with a Debt / Equity ratio of 0.88.
| Current Ratio | 0.90 |
| Quick Ratio | 0.70 |
| Debt / Equity | 0.88 |
| Debt / EBITDA | 2.80 |
| Debt / FCF | 3.48 |
Financial Efficiency
Return on equity (ROE) is 13.10% and return on invested capital (ROIC) is 15.20%.
| Return on Equity (ROE) | 13.10% |
| Return on Assets (ROA) | 4.90% |
| Return on Capital (ROIC) | 15.20% |
| Revenue Per Employee | $525,030 |
| Profits Per Employee | $56,347 |
| Employee Count | 83,500 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 1.71 |
Taxes
| Income Tax | -499.00M |
| Effective Tax Rate | -11.86% |
Stock Price Statistics
The stock price has increased by +8.73% in the last 52 weeks. The beta is 0.18, so AstraZeneca's price volatility has been lower than the market average.
| Beta (1Y) | 0.18 |
| 52-Week Price Change | +8.73% |
| 50-Day Moving Average | 72.56 |
| 200-Day Moving Average | 66.04 |
| Average Volume (30 Days) | 4,049,826 |
Short Selling Information
| Short Interest | 4.67M |
| Short Previous Month | 5.81M |
| Short % of Shares Out | 0.27% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.24 |
Income Statement
In the last 12 months, AstraZeneca had revenue of $43.84 billion and earned $4.71 billion in profits. Earnings per share was $1.51.
| Revenue | 43.84B |
| Gross Profit | 33.06B |
| Operating Income | 5.43B |
| Pretax Income | 4.21B |
| Net Income | 4.71B |
| EBITDA | 11.25B |
| EBIT | 5.58B |
| Earnings Per Share (EPS) | $1.51 |
Balance Sheet
The company has $6.46 billion in cash and $31.50 billion in debt, giving a net cash position of -$25.04 billion or -$8.08 per share.
| Cash & Cash Equivalents | 6.46B |
| Total Debt | 31.50B |
| Net Cash | -25.04B |
| Net Cash Per Share | -$8.08 |
| Equity / Book Value | 35.79B |
| Book Value Per Share | 11.55 |
| Working Capital | -2.59B |
Cash Flow
In the last 12 months, operating cash flow was $9.71 billion and capital expenditures -$650.00 million, giving a free cash flow of $9.06 billion.
| Operating Cash Flow | 9.71B |
| Capital Expenditures | -650.00M |
| Free Cash Flow | 9.06B |
| FCF Per Share | $2.92 |
Margins
Gross margin is 75.40%, with operating and profit margins of 12.38% and 10.73%.
| Gross Margin | 75.40% |
| Operating Margin | 12.38% |
| Pretax Margin | 9.59% |
| Profit Margin | 10.73% |
| EBITDA Margin | 25.67% |
| EBIT Margin | 12.73% |
| FCF Margin | 20.66% |
Dividends & Yields
This stock pays an annual dividend of $2.39, which amounts to a dividend yield of 3.30%.
| Dividend Per Share | $2.39 |
| Dividend Yield | 3.30% |
| Earnings Yield | 2.09% |
| FCF Yield | 4.03% |
| Dividend Growth (YoY) | 13.85% |
| Payout Ratio | 158.41% |
| Buyback Yield | 0.06% |
| Shareholder Yield | 3.36% |
Analyst Forecast
The average price target for AstraZeneca is $79.00, which is 8.94% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $79.00 |
| Price Target Difference | 8.94% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 6.46% |
| EPS Growth Forecast (5Y) | 40.60% |
Stock Splits
The last stock split was on July 27, 2015. It was a forward split with a ratio of 2:1.
| Last Split Date | Jul 27, 2015 |
| Split Type | Forward |
| Split Ratio | 2:1 |